SuperworthTilray Brands revenue TLRY
Sales by quarter and over the last twelve months, from 2017.
- Last 12 months, to Aug 31, 2026
- $963.1M
- Latest quarter, Q1 FY27
- $257.1M
- +23% on a year earlier
- Fiscal year 2026
- $915.5M
- +11% on the year before
Tilray Brands' revenue was $963.1M over the twelve months to Aug 31, 2026, up 16% on a year earlier.
In its latest quarter, Q1 FY27, it was $257.1M, up 23% on the same quarter a year before.
Revenue over time
Fiscal year by fiscal year
| Fiscal year | Revenue | Change |
|---|---|---|
| FY2026 | $915.5M | +11% |
| FY2025 | $821.3M | +4% |
| FY2024 | $788.9M | +26% |
| FY2023 | $627.1M | −0% |
| FY2022 | $628.4M | n/a |
| FY2021 | n/a | n/a |
| FY2020 | n/a | n/a |
| FY2020 | n/a | n/a |
| FY2019 | n/a | n/a |
| FY2018 | $43.1M | +110% |
| FY2017 | $20.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Revenue | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | $257.1M | +23% | $963.1M | |
| Q4 FY26 | $281.7M | +25% | $915.5M | |
| Q3 FY26 | $206.7M | +11% | $858.3M | |
| Q2 FY26 | $217.5M | +3% | $837.3M | |
| Q1 FY26 | $209.5M | +5% | $830.8M | |
| Q4 FY25 | $224.5M | −2% | $821.3M | |
| Q3 FY25 | $185.8M | −1% | $826.7M | |
| Q2 FY25 | $210.9M | +9% | $829.2M | |
| Q1 FY25 | $200M | +13% | $812M | |
| Q4 FY24 | $229.9M | +25% | $788.9M | |
| Q3 FY24 | $188.3M | +29% | $743.2M | |
| Q2 FY24 | $193.8M | +34% | $700.5M |
Against its peers
Companies in Chemicals nearest Tilray Brands' size, closest first, today.
| Company | Revenue, 12 months | Growth |
|---|---|---|
| TLRYTilray Brands | $963.1M | +16% a year |
| FTKFlotek Industries | $293M | +37% a year |
| NAGENiagen Bioscience | $129.1M | +11% a year |
| CRONCronos | $179.1M | +37% a year |
| FTLFFitlife Brands | $101.3M | +61% a year |
| ROGRogers | $834.8M | +5% a year |
| NGVTIngevity | $1.2B | −4% a year |
| IOSPInnospec | $1.8B | +3% a year |
| FULFuller H B | $3.6B | +1% a year |
| WDFCWD 40 | $674.7M | +10% a year |
| AVNTAvient | $3.3B | +2% a year |
| Peer median | $754.7M |
Where Tilray Brands ranks
What the revenue tells you
Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.
Growing revenue with shrinking margins is a warning, not a win.
More on Tilray Brands
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.